BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7946321)

  • 1. Quantification of mitochondrial DNA in heteroplasmic fibroblasts with competitive PCR.
    Wang H; Fliegel L; Cass CE; Penn AM; Michalak M; Weiner JH; Lemire BD
    Biotechniques; 1994 Jul; 17(1):76-8, 80, 82. PubMed ID: 7946321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion screening of mitochondrial DNA via multiprimer DNA amplification.
    Ernst BP; Wilichowski E; Wagner M; Hanefeld F
    Mol Cell Probes; 1994 Feb; 8(1):45-9. PubMed ID: 8028607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue distribution and transmission of mitochondrial DNA deletions in mitochondrial myopathies.
    Zeviani M; Gellera C; Pannacci M; Uziel G; Prelle A; Servidei S; DiDonato S
    Ann Neurol; 1990 Jul; 28(1):94-7. PubMed ID: 2375642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial cytochrome b gene deletion in Kearns-Sayre syndrome associated with a subclinical type of peripheral neuropathy.
    Zanssen S; Molnar M; Buse G; Schröder JM
    Clin Neuropathol; 1998; 17(6):291-6. PubMed ID: 9832255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of OXPHOS gene transcripts during muscle cell differentiation in patients with mitochondrial myopathies.
    Bonod-Bidaud C; Giraud S; Mandon G; Mousson B; Stepien G
    Exp Cell Res; 1999 Jan; 246(1):91-7. PubMed ID: 9882518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nucleotide mapping and a kinetic model of a heteroplasmic deletion of 4,666 base pairs from mitochondrial DNA in the Kearns-Sayre syndrome].
    Nelson I; d'Auriol L; Galibert F; Ponsot G; Lestienne P
    C R Acad Sci III; 1989; 309(10):403-7. PubMed ID: 2514965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mitochondrial DNA deletions in Kearns-Sayre syndrome].
    Carod-Artal FJ; Lopez Gallardo E; Solano A; Dahmani Y; Herrero MD; Montoya J
    Neurologia; 2006 Sep; 21(7):357-64. PubMed ID: 16977556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mitochondrial DNA mutations in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome].
    Wang ZX; Yuan Y; Gao F; Qi Y; Shen DG; Chen QT
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Aug; 20(4):273-8. PubMed ID: 12903032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of Kearns-Sayre syndrome with the 4,977-bp common deletion associated with a novel 7,704-bp deletion.
    Vázquez-Acevedo M; Vázquez-Memije ME; Mutchinick OM; Morales JJ; García-Ramos G; González-Halphen D
    Neurol Sci; 2002 Dec; 23(5):247-50. PubMed ID: 12522683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common and cell type-specific responses of human cells to mitochondrial dysfunction.
    Miceli MV; Jazwinski SM
    Exp Cell Res; 2005 Jan; 302(2):270-80. PubMed ID: 15561107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gene mutation in mitochondrial DNA disease].
    Ozawa T; Sugiyama S; Tanaka M
    Tanpakushitsu Kakusan Koso; 1990 Dec; 35(17):3104-12. PubMed ID: 2287728
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitation of mitochondrial DNA in human lymphoblasts by a competitive polymerase chain reaction method: application to the study of inhibitors of mitochondrial DNA content.
    Zhang H; Cooney DA; Sreenath A; Zhan Q; Agbaria R; Stowe EE; Fornace AJ; Johns DG
    Mol Pharmacol; 1994 Dec; 46(6):1063-9. PubMed ID: 7808425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kearns-Sayre syndrome with sideroblastic anemia: molecular investigations.
    Nelson I; Bonne G; Degoul F; Marsac C; Ponsot G; Lestienne P
    Neuropediatrics; 1992 Aug; 23(4):199-205. PubMed ID: 1407387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of a high mobility group-like protein with human mitochondrial DNA.
    Wang H; Lemire BD; Cass CE; Weiner JH; Michalak M; Singh D; Fliegel L
    Arch Biochem Biophys; 1997 Oct; 346(2):193-202. PubMed ID: 9343366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neurological evolution of Pearson syndrome: case report and literature review.
    Lee HF; Lee HJ; Chi CS; Tsai CR; Chang TK; Wang CJ
    Eur J Paediatr Neurol; 2007 Jul; 11(4):208-14. PubMed ID: 17434771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion in blood mitochondrial DNA in Kearns-Sayre syndrome.
    Fischel-Ghodsian N; Bohlman MC; Prezant TR; Graham JM; Cederbaum SD; Edwards MJ
    Pediatr Res; 1992 Jun; 31(6):557-60. PubMed ID: 1635816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual clinical presentation of a patient carrying a novel single 1.8 kb deletion of mitochondrial DNA.
    Zoccolella S; Torraco A; Amati A; Lamberti P; Serlenga L; Papa S; Petruzzella V
    Funct Neurol; 2006; 21(1):39-41. PubMed ID: 16735000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial DNA deletion in a girl with manifestations of Kearns-Sayre and Lowe syndromes: an example of phenotypic mimicry?
    Moraes CT; Zeviani M; Schon EA; Hickman RO; Vlcek BW; DiMauro S
    Am J Med Genet; 1991 Dec; 41(3):301-5. PubMed ID: 1789283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kearns-Sayre syndrome case presenting a mitochondrial DNA deletion with unusual direct repeats and a rudimentary RNAase mitochondrial ribonucleotide processing target sequence.
    Remes AM; Peuhkurinen KJ; Herva R; Majamaa K; Hassinen IE
    Genomics; 1993 Apr; 16(1):256-8. PubMed ID: 7683627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical diagnosis and molecular genetics of kearns-sayre syndrome: a complex mitochondrial encephalomyopathy.
    Maceluch JA; Niedziela M
    Pediatr Endocrinol Rev; 2006 Dec-2007 Jan; 4(2):117-37. PubMed ID: 17342029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.